Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
Subscribe To Our Newsletter & Stay Updated